Tamar Abrams had a lousy couple of years in 2022 and ’23. Both her parents died; a relationship ended; she retired from communications consulting. She moved from Arlington, Virginia, to Warren, Rhode ...
Robert F. Kennedy Jr. made a lot of promises on his way to becoming health secretary. He pledged to Make America Healthy Again, of course, and to restore trust in embattled health agencies. And he ...
FDA truncates drug approval process; Makary pushes for more OTC drugs; Inside the rocky ride for Recursion Pharmaceuticals.
News you should know, including a look at Big Bear's snow totals; the latest disagreement between CBS and Stephen Colbert; and more!
FDA Commissioner Dr. Marty Makary explains the agency’s decision to lift the warning on hormone replacement therapy and addresses safety and supply concerns.
Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and ...
A system that allows drug makers to profit from restricted access will never liberalize on its own—and patients will continue ...
In a NEJM article, Commissioner Martin Makary and top deputy Vinay Prasad argued that the new policy should lower development ...
Drug sponsors should nevertheless bolster their application with “confirmative evidence,” chief regulators Marty Makary and Vinay Prasad said on Wednesday, including mechanistic data or findings from ...
Hims & Hers Health faced backlash after launching a semaglutide weight-loss pill, leading to a lawsuit from Novo Nordisk for patent infringement. The move aimed to drive growth but resulted in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results